Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-19-000042
Filing Date
2019-08-01
Accepted
2019-08-01 07:38:55
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q q2201910-q.htm 10-Q 1289641
2 EXHIBIT 31.1 q22019exhibit311.htm EX-31.1 12542
3 EXHIBIT 31.2 q22019exhibit312.htm EX-31.2 12640
4 EXHIBIT 32.1 q22019exhibit321.htm EX-32.1 6828
5 EXHIBIT 32.2 q22019exhibit322.htm EX-32.2 6786
12 changeinsalta01.jpg GRAPHIC 75193
13 PIPELINE junepipelinea01.jpg GRAPHIC 72636
14 respondersatweek27.jpg GRAPHIC 41138
  Complete submission text file 0001367920-19-000042.txt   6060247

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20190630.xml EX-101.INS 1196985
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20190630.xsd EX-101.SCH 38766
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20190630_cal.xml EX-101.CAL 74894
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20190630_def.xml EX-101.DEF 201097
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20190630_lab.xml EX-101.LAB 578036
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20190630_pre.xml EX-101.PRE 336103
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 19990971
SIC: 2834 Pharmaceutical Preparations